Advertisements


Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap

At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.....»»

Category: topSource: insidermonkeyMar 20th, 2017

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow.....»»

Category: topSource: seekingalphaMar 20th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Zacks.....»»

Category: topSource: redinewsMar 9th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares rose above 8% on the day. .....»»

Category: topSource: zacksMar 9th, 2017

Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results

ANN ARBOR, Mich., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on d.....»»

Category: earningsSource: benzingaFeb 22nd, 2017

Esperion Surge May Be Fueled By Repatha Short Squeeze

Esperion Therapeutics Inc (NASDAQ: ESPR) has maintained its upward momentum on Tuesday, surging higher by another 13.2 percent. read more.....»»

Category: blogSource: benzingaFeb 7th, 2017

What’s Next For Esperion Therapeutics Inc (ESPR)?

Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unr.....»»

Category: topSource: insidermonkeyFeb 6th, 2017

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference.....»»

Category: topSource: seekingalphaJan 11th, 2017

Esperion Therapeutics Inc (ESPR): Smart Money Doubles Down

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain smal.....»»

Category: topSource: insidermonkeyDec 9th, 2016

Top-Line Data For Esperion"s Bempedoic Acid Creates Question About Whether There Is A Place In The Market For It

Following the release of top-line results from the eight-week mid-state study of Esperion Therapeutics Inc (NASDAQ: ESPR)'s bempedoic acid, Chardan said safety concerns on adding it to high-dose statins triggers a question whether there is any market for .....»»

Category: blogSource: benzingaOct 13th, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Zacks.....»»

Category: topSource: redinewsSep 21st, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares jumped a little over 18% on the day. Esperion Therapeutics, Inc. ESPR was a big mover last session, as its shares rose a little over 18% on the day. The move came on solid.....»»

Category: topSource: zacksSep 21st, 2016

3 Clinical-Stage Biotech Stocks That Could Be About to Strike It Rich

Axovant Sciences, Esperion Therapeutics, and Aerie Pharmaceuticals are developing drugs targeting multibillion-dollar indications......»»

Category: topSource: foxnewsApr 11th, 2017

Buy Esperion Therapeutics Before Big Pharma Does

Buy Esperion Therapeutics Before Big Pharma Does.....»»

Category: topSource: seekingalphaApr 7th, 2017

The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics

The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics.....»»

Category: topSource: zacksApr 7th, 2017

Esperion Therapeutics upgraded to buy from neutral at UBS

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 30th, 2017

Massive Biotech Trade Highlights Insider Selling: Esperion Therapeutics, Adobe, Hilton, Fresh Del Monte and More

While the insider selling slowed somewhat, top executives are still taking the chance to sell shares before the windows for trading start to close for earnings......»»

Category: blogSource: 247wallstMar 25th, 2017

Here"s What Pushed Esperion Therapeutics Inc Stock Higher Today

The Esperion rollercoaster is climbing again after an encouraging signal from the FDA......»»

Category: topSource: foxnewsMar 20th, 2017

Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging

Although the broader markets are relatively calm, five stocks, Nektar Therapeutics (NASDAQ:NKTR), Advanced Micro Devices, Inc. (NASDAQ:AMD), .....»»

Category: topSource: insidermonkeyMar 20th, 2017

Esperion Therapeutics Rockets 70% Higher After Big Selloff

Esperion Th.....»»

Category: blogSource: benzingaMar 20th, 2017

Esperion Therapeutics stock surges 52% after it says the FDA gave its drug program positive feedback

Esperion Therapeutics Inc. shares surged 52.0% in mor.....»»

Category: topSource: marketwatchMar 20th, 2017